MAGDA ELKABANI MELCHERT MD NPI 1376596346

NPI Information

  • NPI: 1376596346
  • Provider Name: MAGDA ELKABANI MELCHERT, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 403 S KINGS AVE STE 100
    BRANDON, FL
    ZIP 33511
  • Phone: (813) 982-3460

Map and Directions

Get Directions

NPI Details

Magda Elkabani Melchert, MD is a medical oncology internal medicine in Brandon, FL with 26 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Magda Elkabani Melchert, MD NPI is 1376596346. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF SOUTH FLORIDA COLLEGE OF MEDICINE
Graduation Year:2000

The provider's business location address is:

403 S KINGS AVE STE 100
BRANDON, FL
ZIP 33511-962
Phone: (813) 982-3460
Fax: (813) 982-3461

The NPI 1376596346 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Blood test, clotting time (HCPCS:85610)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Magnesium level (HCPCS:83735)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Folic acid level, serum (HCPCS:82746)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Automated urinalysis test (HCPCS:81003)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Red blood count, manual test (HCPCS:85044)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Red blood count, automated test (HCPCS:85045)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)

The enumeration date for this NPI number is 5/18/2006 and was last updated on 8/11/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyME88929FLORIDANo
2207RX0202XInternal MedicineMedical OncologyME88929FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1P00727035OTHERFLORIDARR MEDICARE
2275257300MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.